Synergy Pharmaceuticals Inc. (OTC Bulletin Board: SGYP) is going to be giving a presentation at the BIO 2010 Business Forum which is part of the 2010 BIO International Convention. The company’s President and CEO, Dr. Gary S. Jacob, will host their presentation.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
The conference is being held in Chicago, IL at McCormick Place from May 3-6, 2010. The company is scheduled to deliver their presentation in Room A on May 4th at 2:45pm (CST).
Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug SP-304 is a synthetic analog of the human gastrointestinal hormone uroguanylin, and acts by activating the guanylate cyclase C (GC-C) receptor on epithelial cells of the GI tract.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
